These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 28249963)
1. Cell death response to anti-mitotic drug treatment in cell culture, mouse tumor model and the clinic. Shi J; Mitchison TJ Endocr Relat Cancer; 2017 Sep; 24(9):T83-T96. PubMed ID: 28249963 [TBL] [Abstract][Full Text] [Related]
2. Kinesin motor proteins as targets for cancer therapy. Huszar D; Theoclitou ME; Skolnik J; Herbst R Cancer Metastasis Rev; 2009 Jun; 28(1-2):197-208. PubMed ID: 19156502 [TBL] [Abstract][Full Text] [Related]
3. Cell type variation in responses to antimitotic drugs that target microtubules and kinesin-5. Shi J; Orth JD; Mitchison T Cancer Res; 2008 May; 68(9):3269-76. PubMed ID: 18451153 [TBL] [Abstract][Full Text] [Related]
4. Targeting mitosis for anti-cancer therapy. Sudakin V; Yen TJ BioDrugs; 2007; 21(4):225-33. PubMed ID: 17628120 [TBL] [Abstract][Full Text] [Related]
5. How do anti-mitotic drugs kill cancer cells? Gascoigne KE; Taylor SS J Cell Sci; 2009 Aug; 122(Pt 15):2579-85. PubMed ID: 19625502 [TBL] [Abstract][Full Text] [Related]
6. Mitotic drug targets and the development of novel anti-mitotic anticancer drugs. Schmidt M; Bastians H Drug Resist Updat; 2007; 10(4-5):162-81. PubMed ID: 17669681 [TBL] [Abstract][Full Text] [Related]
7. A novel anti-microtubule agent with carbazole and benzohydrazide structures suppresses tumor cell growth in vivo. Ohira M; Iwasaki Y; Tanaka C; Kuroki M; Matsuo N; Kitamura T; Yukuhiro M; Morimoto H; Pang N; Liu B; Kiyono T; Amemiya M; Tanaka K; Yoshida K; Sugimoto N; Ohshima T; Fujita M Biochim Biophys Acta; 2015 Sep; 1850(9):1676-84. PubMed ID: 25960391 [TBL] [Abstract][Full Text] [Related]
8. Post-slippage multinucleation renders cytotoxic variation in anti-mitotic drugs that target the microtubules or mitotic spindle. Zhu Y; Zhou Y; Shi J Cell Cycle; 2014; 13(11):1756-64. PubMed ID: 24694730 [TBL] [Abstract][Full Text] [Related]
9. Development of new cancer therapeutic agents targeting mitosis. Miglarese MR; Carlson RO Expert Opin Investig Drugs; 2006 Nov; 15(11):1411-25. PubMed ID: 17040200 [TBL] [Abstract][Full Text] [Related]
11. Inhibitors targeting mitosis: tales of how great drugs against a promising target were brought down by a flawed rationale. Komlodi-Pasztor E; Sackett DL; Fojo AT Clin Cancer Res; 2012 Jan; 18(1):51-63. PubMed ID: 22215906 [TBL] [Abstract][Full Text] [Related]
12. Advances in mitotic inhibitors for cancer treatment. Jiang N; Wang X; Yang Y; Dai W Mini Rev Med Chem; 2006 Aug; 6(8):885-95. PubMed ID: 16918495 [TBL] [Abstract][Full Text] [Related]
13. An update on the developing mitotic inhibitors for the treatment of non-small cell carcinoma. Sacco PC; Gridelli C Expert Opin Emerg Drugs; 2017 Sep; 22(3):213-222. PubMed ID: 28836854 [TBL] [Abstract][Full Text] [Related]